Vertex Pharmaceuticals, Inc. (VRTX)

Precedente Chiudi:

$392.81

Aprire:

$392.81

Volume 24 ore:

1.24M

Capitalizzazione di mercato:

$103.94B

Reddito:

$9.87B

Utile/perdita netta:

$3.62B

Rapporto P/E:

30.17

EPS:

13.33

Flusso di cassa netto:

$3.28B

1 W Prestazione:

+0.34%

1M Prestazione:

-4.36%

6M Prestazione:

+8.88%

1 anno Prestazione:

+16.56%

Intervallo 1D:

$392.47

$406.95

Portata 52W:

$320.01

$448.40

Vertex Pharmaceuticals, Inc. Stock (VRTX) Company Profile

Nome

Vertex Pharmaceuticals, Inc.

Settore

Healthcare (1189)

Industria

Biotechnology (685)

Telefono

617-341-6100

Indirizzo

50 Northern Avenue, Boston, MA

Dipendente

2,300

Cinguettio

@VertexPharma

Prossima data di guadagno

2024-05-15

Ultimi documenti SEC

VRTX's Discussions on Twitter

Vertex Pharmaceuticals, Inc. Stock (VRTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-15	Iniziato	Wolfe Research	Outperform
2024-02-06	Downgrade	Evercore ISI	Outperform → In-line
2024-02-02	Downgrade	Bernstein	Outperform → Mkt Perform
2024-01-31	Downgrade	Maxim Group	Buy → Hold
2024-01-31	Downgrade	Robert W. Baird	Neutral → Underperform
2024-01-24	Downgrade	Canaccord Genuity	Hold → Sell
2023-12-14	Reiterato	RBC Capital Mkts	Sector Perform
2023-05-30	Iniziato	William Blair	Outperform
2023-05-04	Ripresa	Piper Sandler	Overweight
2023-03-21	Iniziato	Bernstein	Outperform
2023-01-18	Iniziato	Canaccord Genuity	Hold
2023-01-17	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-12-19	Downgrade	Jefferies	Buy → Hold
2022-07-13	Iniziato	Cantor Fitzgerald	Overweight
2022-06-01	Aggiornamento	Maxim Group	Hold → Buy
2022-05-23	Iniziato	SVB Leerink	Mkt Perform
2022-05-06	Downgrade	Robert W. Baird	Outperform → Neutral
2022-05-03	Aggiornamento	Morgan Stanley	Underweight → Equal-Weight
2022-02-03	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-01-27	Reiterato	JP Morgan	Overweight
2022-01-27	Reiterato	Morgan Stanley	Underweight
2022-01-27	Reiterato	RBC Capital Mkts	Outperform
2022-01-27	Reiterato	Stifel	Hold
2022-01-27	Reiterato	Wolfe Research	Outperform
2022-01-20	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2021-12-09	Iniziato	Wells Fargo	Overweight
2021-11-19	Iniziato	BMO Capital Markets	Market Perform
2021-11-19	Downgrade	Piper Sandler	Overweight → Neutral
2021-09-09	Downgrade	Stifel	Buy → Hold
2021-09-07	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2021-07-20	Downgrade	SVB Leerink	Mkt Perform → Underperform
2021-07-19	Ripresa	Wolfe Research	Outperform
2021-07-01	Iniziato	Raymond James	Mkt Perform
2021-06-11	Downgrade	Daiwa Securities	Outperform → Neutral
2021-02-23	Aggiornamento	Robert W. Baird	Neutral → Outperform
2021-02-02	Reiterato	H.C. Wainwright	Buy
2020-12-30	Iniziato	Daiwa Securities	Outperform
2020-11-30	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2020-11-20	Iniziato	Bernstein	Outperform
2020-10-28	Iniziato	UBS	Buy
2020-07-31	Reiterato	H.C. Wainwright	Buy
2020-07-08	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-04-30	Reiterato	H.C. Wainwright	Buy
2020-04-28	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2020-03-04	Iniziato	Barclays	Overweight
2020-01-31	Downgrade	Robert W. Baird	Outperform → Neutral
2019-11-19	Aggiornamento	Guggenheim	Neutral → Buy
2019-11-12	Iniziato	SunTrust	Buy
2019-10-17	Ripresa	BofA/Merrill	Buy
2019-09-03	Aggiornamento	Goldman	Neutral → Buy
2019-08-01	Downgrade	Needham	Buy → Hold
2019-05-23	Ripresa	Citigroup	Buy
2019-05-21	Iniziato	Credit Suisse	Outperform
2019-04-12	Iniziato	Evercore ISI	In-line
2019-03-26	Aggiornamento	William Blair	Mkt Perform → Outperform
2019-03-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-02-06	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

Vertex Pharmaceuticals, Inc. Borsa (VRTX) Ultime notizie

Will Arcus Biosciences, Inc. (RCUS) Report Negative Earnings Next Week? What You Should Know

Zacks Investment Research

Unveiling Vertex (VRTX) Q1 Outlook: Wall Street Estimates for Key Metrics

Zacks Investment Research

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?

Zacks Investment Research

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Zacks Investment Research

2 Top Growth Stocks to Buy Right Now and Hold Forever

The Motley Fool

Vertex Pharmaceuticals, Inc. Azioni (VRTX) Dati Finanziari

Vertex Pharmaceuticals, Inc. (VRTX) Reddito 2024

Vertex Pharmaceuticals, Inc. (VRTX) Reddito netto 2024

Vertex Pharmaceuticals, Inc. (VRTX) Flusso di cassa 2024

Vertex Pharmaceuticals, Inc. (VRTX) Utile per azione 2024

Vertex Pharmaceuticals, Inc. Azioni (VRTX) insider trading